|
Prescription Drug Search
Strengths available for Zetia:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Zetia:
- Albania
- Argentina
- Armenia
- Aruba
- Bahrain
- Barbados
- Belarus
- Bermuda
- Bolivia
- Chile
- Costa Rica
- Dominican Republic
- Ecuador
- Gibraltar
- Greece
- Hong Kong
- India
- Iran
- Italy
- Jamaica
- Kuwait
- Luxembourg
- Netherlands
- New Zealand
- Paraguay
- Serbia
- Slovenia
- South Africa
- Sweden
- Switzerland
- Taiwan
- Tunisia
- Ukraine
- United Arab Emirates
- United Kingdom, UK
- United States, US
- Uzbekistan
- Vanuatu
- Vietnam
- Yemen
Latest news releases on Zetia:
CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety - Marketwatch
The FDA issued an early communication after results from the ENHANCE trial indicated that adding ezetimibe (known as either Zetia or the ezetimibe-simvastatin combination, Vytorin) to a treatment regimen including simvastatin did not appear to ...
Merck: Manufacturing Portfolio Health With Dividend Income - Seekingalpha.com
It could face market backlash if it is withdrawn like a similar drug recently by Roche. Two of their major revenue generators, Zetia and Vytorian, will continue to be available only through Merck until 2017. The company was successfully able to thwart ...
Glenmark's different route to US drug market - Business Standard
It also wants to launch a low-cost version of a major drug, Zetia by Merck, in 2017-17 in the US, with similar rights to tap a significant share in the market. The drug has a market size of around $1.4 billion. Glenmark is already enjoying marketing ...
FDA to investigate possible Vytorin-cancer link - Xagena Medical News
Ezetimibe ( Zetia ), approved in 2002, inhibits the absorption of cholesterol in the intestine and is indicated to reduce LDL-cholesterol levels. Vytorin, the combination product approved in 2004, is indicated to reduce LDL-cholesterol levels. Recently ...
